Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.07%
0%
-11.07%
6 Months
-11.07%
0%
-11.07%
1 Year
-42.21%
0%
-42.21%
2 Years
-30.69%
0%
-30.69%
3 Years
-45.75%
0%
-45.75%
4 Years
-34.9%
0%
-34.9%
5 Years
-34.9%
0%
-34.9%
Fielmann Group AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.28%
EBIT Growth (5y)
-14.20%
EBIT to Interest (avg)
20.80
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
1.63
Tax Ratio
28.96%
Dividend Payout Ratio
63.50%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
34.02%
ROE (avg)
18.65%
Valuation key factors
Factor
Value
P/E Ratio
38
Industry P/E
Price to Book Value
4.40
EV to EBIT
37.09
EV to EBITDA
19.20
EV to Capital Employed
3.82
EV to Sales
1.95
PEG Ratio
NA
Dividend Yield
2.29%
ROCE (Latest)
10.30%
ROE (Latest)
11.63%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Mar 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY
Dec'24
Dec'23
Change(%)
Net Sales
577.90
471.70
22.51%
Operating Profit (PBDIT) excl Other Income
109.70
71.50
53.43%
Interest
19.50
8.30
134.94%
Exceptional Items
0.00
0.00
Consolidate Net Profit
26.80
11.20
139.29%
Operating Profit Margin (Excl OI)
82.90%
55.00%
2.79%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2024 is 22.51% vs 6.70% in Dec 2023
Consolidated Net Profit
YoY Growth in quarter ended Dec 2024 is 139.29% vs -0.88% in Dec 2023
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2,264.10
1,970.90
14.88%
Operating Profit (PBDIT) excl Other Income
457.20
384.10
19.03%
Interest
18.80
13.10
43.51%
Exceptional Items
-0.40
-8.30
95.18%
Consolidate Net Profit
154.20
127.80
20.66%
Operating Profit Margin (Excl OI)
107.20%
95.40%
1.18%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 14.88% vs 12.05% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 20.66% vs 16.50% in Dec 2023
About Fielmann Group AG 
Fielmann Group AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






